Human-murine chimeric antibodies against respiratory syncytial virus
CA 2197684 C · Owner: Medimmune, Inc. · Inventors: Johnson, Leslie Sid
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one muring monoclonal antibody against respiratory syncytial virus which is MAb1129 and the use thereof for the prevention and/or treatment of RSV infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 9, 1995 and granted October 31, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 9, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 9, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.